Final-Program-ATS-2023-AP.vp

28

SATURDAY • MAY 20

2:40 Tough Cases

Objectives At the conclusion of this session, the participant will be able to: • be able to apply a consistent, effective strategy to ILD/IPF diagnosis • understand the range of therapeutics available for ILD and how and when to prescribe them • be able to integrate a holistic and interdisciplinary approach to ILD patient care This course will provide a practical approach to the diagnosis and management of patients with ILD. It will bring recommendations and guidelines into a usable strategy that will facilitate the care of patients with ILD. This will occur through didactics, simulated MDD, and panel discussions of difficult cases with audience engagment through audience response which will provide a range of learning strategies to help the largest number of learners. Chairing: M. Kreider, MD, MSCE, ATSF, Philadelphia, PA S.K. Danoff, MD, PhD, ATSF, Baltimore, MD 8:00 Introduction M. Kreider, MD, MSCE, ATSF, Philadelphia, PA 8:10 Clinical Evaluation of the New ILD Patient S. Sood, MD, MS, Philadelphia, PA 8:35 New Guidelines for the Diagnosis of ILD K.I. Aronson, MD, MSci, New York, NY 9:00 Recognizing CT Patterns S. Hobbs, MD, Lexington, KY 9:25 Patients at Risk for ILD R.K. Putman, MD, MPH, Boston, MA 9:50 Break 10:20 Natural History of Disease and Monitoring A.O. Adegunsoye, MD, MS, Chicago, IL 10:45 Speed MDD S.K. Danoff, MD, PhD, ATSF, Baltimore, MD K.I. Aronson, MD, MSci, New York, NY S. Sood, MD, MS, Philadelphia, PA L.P. Hariri, MD, PhD, ATSF, Boston, MA

M. Kreider, MD, MSCE, ATSF, Philadelphia, PA R.K. Putman, MD, MPH, Boston, MA A.O. Adegunsoye, MD, MS, Chicago, IL T.J. Corte, MBBS, BScM, PhD, Sydney, Australia M. Wijsenbeek, MD, PhD, Rotterdam, Netherlands S.K. Danoff, MD, PhD, ATSF, Baltimore, MD V. Steen, MD, Washington, DC L.P. Hariri, MD, PhD, ATSF, Boston, MA S. Hobbs, MD, Lexington, KY A. Calypso, MSN, CRNP, Baltimore, MD

3:50 Wrap-Up

S.K. Danoff, MD, PhD, ATSF, Baltimore, MD This session and the International Conference are supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. All CME sessions have been planned and implemented in accordance with the Accreditation Criteria of the Accreditation Council for Continuing Medical Education (ACCME®) and are free of the control of ineligible companies (formerly commercial interests). BASIC • BEHAVIORAL • CLINICAL • TRANSLATIONAL POSTGRADUATE COURSE CME Credits Available: 6 PG9 FUND ME: OVERCOMING THE BARRIERS AND CHALLENGES TO SUCCESSFUL CAREER DEVELOPMENT AWARDS R Pre-registration and additional fees required. Attendance is limited. Member: $440 In-Training Member: $255 LMIC Member: $310 LMIC In-Training Member: $180 Non-Member: $540 In-Training Non-Member: $380 Assemblies on Critical Care, Behavioral Science and Health Services Research, Clinical Problems, Nursing, Pediatrics, Pulmonary Infections and Tuberculosis, Respiratory Cell and Molecular Biology; Supported by MITT 8:00 AM - 4:00 PM Marriott Marquis Washington Independence Ballroom, Salon E (Level M4) Target Audience Early-stage investigators (fellows, junior faculty, advanced practice nurses, PhDs) interested in submitting clinical, translational, health services, or implementation science F, K, or other career development awards. Objectives At the conclusion of this session, the participant will be able to: • compose a competitive mentored grant award application with an emphasis on innovative research and training plans that highlight the candidate’s potential as well as the strength of their mentorship team and institutional environment

S. Hobbs, MD, Lexington, KY V. Steen, MD, Washington, DC A.O. Adegunsoye, MD, MS, Chicago, IL

11:55 Lunch 12:55 Therapies for Pulmonary Fibrosis 1:20 Therapies for CTD-ILD F. Castelino, MD, Boston, MA 1:45 Non-Pharmacologic Care in ILD

T.J. Corte, MBBS, BScM, PhD, Sydney, Australia

M. Wijsenbeek, MD, PhD, Rotterdam, Netherlands

2:10 Break

ATS 2023 • Washington, DC